These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 2593316

  • 21. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.
    Hirano T, Akashi T, Keira T, Oka K, Ihoya N, Yoshida M.
    Clin Pharmacol Ther; 2000 Nov; 68(5):532-40. PubMed ID: 11103756
    [Abstract] [Full Text] [Related]

  • 22. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
    Tsuchihashi M, Sakaguchi Y, Nakamura M, Sutani T, Tsuruta S, Kato S, Uemura S, Nishida Y, Hashimoto T, Kagoshima T.
    J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146
    [Abstract] [Full Text] [Related]

  • 23. [Multidisciplinary therapy using interferon and immunological evaluation for glioma patients: two-color analysis of T cell subsets].
    Numa Y, Kawamoto K, Matsumura H.
    No Shinkei Geka; 1991 Feb; 19(2):121-8. PubMed ID: 1708857
    [Abstract] [Full Text] [Related]

  • 24. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.
    James SP, Neckers LM, Graeff AS, Cossman J, Balch CM, Strober W.
    Gastroenterology; 1984 Jun; 86(6):1510-8. PubMed ID: 6232165
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
    Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S.
    Nephrol Dial Transplant; 1994 Jun; 9(3):257-64. PubMed ID: 8052431
    [Abstract] [Full Text] [Related]

  • 29. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM, Golub SH.
    Nat Immun Cell Growth Regul; 1994 Jun; 3(4):193-202. PubMed ID: 6241293
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Lymphocyte subsets in Sjogren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence-activated cell sorter.
    Bakhshi A, Miyasaka N, Kavathas P, Daniels TE, Strand CV, Herzenberg LA, Talal N.
    J Clin Lab Immunol; 1983 Feb; 10(2):63-9. PubMed ID: 6601716
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunological mechanisms in glomerulonephritis. A short review and analysis of peripheral mononuclear cell subsets in IgA nephropathy and membranous glomerulonephritis.
    Pettersson E, von Willebrand E, Honkanen E.
    Scand J Urol Nephrol Suppl; 1985 Feb; 90():29-34. PubMed ID: 3879379
    [Abstract] [Full Text] [Related]

  • 37. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
    Taira K, Hewitson TD, Kincaid-Smith P.
    Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.